Rate pressure product as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: a retrospective cohort study

被引:2
|
作者
Jiang, Zhi-Hui [1 ]
Aierken, Abudula [1 ]
Wu, Ting-Ting [1 ]
Zheng, Ying-Ying [1 ]
Ma, Yi-Tong [1 ]
Xie, Xiang [1 ]
机构
[1] Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China
来源
BMJ OPEN | 2023年 / 13卷 / 04期
基金
中国国家自然科学基金;
关键词
Coronary heart disease; Coronary intervention; Cardiology; Myocardial infarction; GERIATRIC MEDICINE; BLOOD-PRESSURE; HEART-RATE; ARTERY-DISEASE; IMPACT; EXERCISE;
D O I
10.1136/bmjopen-2022-067951
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Previous studies have suggested that heart rate and blood pressure play important roles in the development of adverse outcomes in patients with coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI). However, the relationship between the rate pressure product (RPP) and long-term outcomes has rarely been investigated. This study investigated the effects of RPP on the clinical outcomes of patients with CAD who underwent PCI. Design In this study, a total of 6015 patients with CAD were enrolled. All patients were from the CORFCHD-PCI (Clinical Outcomes and Risk Factors of Patients with Coronary Heart Disease after PCI) Study. They were divided into two groups according to RPP (RPP <10269, n=4018and RPP >= 10269, n=1997). In addition, the median follow-up time was 32 months. Participants Data was obtained from 6050 patients with CAD who underwent PCI at the First Affiliated Hospital of Xinjiang Medical University from January 2008 to December 2016. Primary and secondary outcome measures The primary endpoint was long-term mortality, including all-cause mortality (ACM) and cardiac mortality (CM). The secondary endpoints were major adverse cardiovascular events (MACEs) and major adverse cardiovascular and cerebrovascular events (MACCEs). Results We found that there were significant differences between the two groups in the incidence of ACM, CM, MACCEs and MACEs (all p<0.05). Among the patients with CAD having ACM, CM, MACCEs and MACEs, the mean survival time of the low-value group was significantly higher than that of the high-value group. Multivariate Cox regression analyses showed that RPP was an independent predictor for ACM (HR=1.605, 95% CI: 1.215-2.120, p=0.001), CM (HR=1.733, 95%CI: 1.267-2.369, p=0.001), MACCEs (HR=1.271, 95%CI: 1.063-1.518, p=0.008) and MACEs (HR=1.315, 95%CI: 1.092-1.584, p=0.004) in patients with stable CAD. On the other hand, there was no significant correlation between the RPP and the adverse outcomes in patients with acute coronary syndrome. Conclusion In summary, RPP is an independent predictor of long-term prognosis in patients with CAD who underwent PCI. A higher baseline RPP before PCI increased the risk of adverse outcomes. Compared with heart rate and blood pressure alone, RPP has a higher predictive value for adverse clinical outcomes.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Rate-Pressure Product is a Novel Predictor for Short- and Long-Term Mortality in Patients with Acute Coronary Syndrome Undergoing Primary PCI/Immediate Invasive Strategy
    Zhou, Jian
    Li, Ya-Jie
    Zhou, Xiao-Dong
    Wang, Li-Juan
    CLINICAL INTERVENTIONS IN AGING, 2024, 19 : 571 - 579
  • [42] Short- and long-term outcomes following percutaneous coronary intervention in hepatitis C virus seropositive patients
    Hussein, Ahmed
    Abdel Ghany, Mohamed
    Mahmoud, Hossam Eldin M.
    EGYPTIAN HEART JOURNAL, 2020, 72 (01)
  • [43] Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry
    Kang, Jeehoon
    Yun, Junpil
    Park, Kyung Woo
    Park, Minae
    Park, Sojeong
    Hwang, Doyeon
    Han, Jung-Kyu
    Yang, Han-Mo
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Angiolillo, Dominick J.
    Urban, Philip
    Kim, Hyo-Soo
    EUROPEAN HEART JOURNAL, 2024, 45 (36) : 3721 - 3731
  • [44] Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: A randomized, controlled study
    Han, Yaling
    Li, Yi
    Wang, Shouli
    Jing, Quanmin
    Wang, Zhulu
    Wang, Dongmei
    Shu, Qingfen
    Tang, Xiuying
    AMERICAN HEART JOURNAL, 2009, 157 (04) : 733 - 739
  • [45] Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention
    Tscharre, Maximilian
    Herman, Robert
    Rohla, Miklos
    Piackova, Edita
    Vargas, Kris G.
    Farhan, Serdar
    Freynhofer, Matthias K.
    Weiss, Thomas W.
    Huber, Kurt
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (01) : 115 - 122
  • [46] Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents
    Rossini, Roberta
    Musumeci, Giuseppe
    Aprile, Alessandro
    Valsecchi, Orazio
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (01) : 49 - 61
  • [47] Trends in Cause of Long-Term Death After Percutaneous Coronary Intervention
    Spoon, Daniel B.
    Psaltis, Peter J.
    Singh, Mandeep
    Holmes, David R.
    Gersh, Bernard K.
    Rihal, Charanjit S.
    Lennon, Ryan J.
    Moussa, Issam D.
    Simari, Robert D.
    Gulati, Rajiv
    CIRCULATION, 2013, 128 (22)
  • [48] Long-term clinical outcomes after percutaneous coronary intervention for chronic total occlusions in elderly patients (75 Years)
    Hoebers, Loes P.
    Claessen, Bimmer E.
    Dangas, George D.
    Park, Seung-Jung
    Colombo, Antonio
    Moses, Jeffrey W.
    Henriques, Jose P. S.
    Stone, Gregg W.
    Leon, Martin B.
    Mehran, Roxana
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 82 (01) : 85 - 92
  • [49] Impact of gender differences on long-term outcomes after successful percutaneous coronary intervention in patients with acute myocardial infarction
    Woo, Jong Shin
    Kim, Weon
    Ha, Sang Jin
    Kim, Soo Joong
    Kang, Won Yu
    Jeong, Myung Ho
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 145 (03) : 516 - 518
  • [50] Effect of Polypharmacy on Long-Term Mortality After Percutaneous Coronary Intervention
    Yamamoto, Ko
    Natsuaki, Masahiro
    Morimoto, Takeshi
    Shiomi, Hiroki
    Ozasa, Neiko
    Sakamoto, Hiroki
    Takeji, Yasuaki
    Imada, Kazuaki
    Tada, Takeshi
    Taniguchi, Ryoji
    Uegaito, Takashi
    Yamada, Miho
    Takeda, Teruki
    Eizawa, Hiroshi
    Suwa, Satoru
    Shirotani, Manabu
    Tamura, Toshihiro
    Inoko, Moriaki
    Sakai, Hiroshi
    Yamamoto, Takashi
    Ishii, Katsuhisa
    Takahashi, Mamoru
    Tamura, Takashi
    Miki, Shinji
    Onodera, Tomoya
    Furukawa, Yutaka
    Tanaka, Masaru
    Ando, Kenji
    Kadota, Kazushige
    Nakagawa, Yoshihisa
    Kimura, Takeshi
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 159 : 19 - 29